Lifting and longevity: is 1 hour a week really the limit? Plus GLP1s and mood, training with ME/CFS, and Protein vs. Calories

12 Aug 2026 · 46 min · 11 chapters

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Debunks a 2022 British Journal of Sports Medicine headline claiming resistance training’s longevity benefit disappears after ~60 minutes/week; discusses GLP-1s’ effects on mood/motivation; addresses “protein vs calories” weight-loss claims; and gives practical guidance for weightlifting with ME/CFS (post-exertional malaise).

Guests

No named guests in the provided transcript; the hosts are Dr. Jordan Feigenbaum and Austin (a clinician/prescriber).

Key claims

“Any lifting beats nothing,” and the “60 minutes” threshold is likely an artifact of self-reported training time, limited high-volume representation, and using time rather than training stress/adaptation outcomes. GLP-1s: average mood/depression risk is not worse; rare “flat” effects are more common at highest doses and are often dose-manageable. Protein/keto: weight loss still follows energy intake; protein studies often show lower actual calories; keto “eating more” is usually misperceived lower intake.

Notable examples

Meta-analysis: ~15% lower all-cause mortality with strength training; ~40% reduction when meeting strength+cardio guidelines. Harvard cohort (Zhang): benefit dose-response up to ~2 hours/week. GLP-1 psychiatric safety: FDA reviewed 91 placebo trials (~108k patients) plus real-world data; suicidal-ideation concern walked back. ME/CFS: post-exertional malaise; identical-twin exercise test showed ~13% larger drop at anaerobic threshold on day 2 in the ME/CFS twin; guidance favors staying under crash threshold, shorter sessions, lower RPE, longer rests, and double progression.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Chapters

Tap a time to open that second in VO

Debunking the One Hour Training Myth

0:38 to 4:28

Exploring the study claiming lifting benefits disappear past one hour per week.

“This is about lifting weights for more than one hour per week.”

The Dose-Response Relationship of Exercise

4:28 to 8:40

Discussing the correlation between exercise volume and health benefits.

“maybe double the current physical activity guidelines for health benefit, maybe even a little lower.”

Clinical Implications and Patient Counseling

8:40 to 13:08

How to frame exercise recommendations for patients based on their current activity levels.

“or compromise your longevity, you know, gains from this kind of thing.”

Clinical Implications and Patient Counseling

15:53 to 16:58

How to frame exercise recommendations for patients based on their current activity levels.

“End of summer is when I start thinking about what I actually want in my closet for the next few months.”

Exploring GLP-1 Medications and Mental Health Effects

18:58 to 24:15

Discussion on how GLP-1 medications impact mood, motivation, and psychiatric risks.

“Will we ever sufficiently talk about GLP-1s such that all of the questions have been answered?”

Patient Counseling on GLP-1 Usage

24:15 to 28:01

Advice on how to counsel patients regarding the use of GLP-1 medications.

“Which on the one hand was like a silver lining.”

Counseling on GLP-1 Medications

28:01 to 30:32

Learn about counseling strategies for patients using GLP-1 medications.

“somebody's not really taking an unregulated peptide from the gray market here.”

Understanding Protein and Calories

30:33 to 37:10

Explore the nuances of protein intake and its effects on weight loss.

“So the question is, can you discuss the nuance around the studies showing weight loss when protein goes up, even at the same or higher calories?”

Managing Chronic Fatigue Syndrome with Exercise

37:11 to 42:00

Discuss effective exercise strategies for those with chronic fatigue syndrome.

“And that means that if the ultimate goal of this is for their health, then yes, as long as they are making progress, losing in a way that they prefer, then yes, I'm on their team for that.”

Understanding Chronic Fatigue Syndrome and Exercise

42:00 to 46:04

Explore the impact of chronic fatigue syndrome on exercise tolerance and the evolving guidance for training.

“The healthy twin repeated their performance on day two just fine.”
Show all 11 chapters

Counseling Strategies for Patients with Chronic Fatigue

46:04 to 49:51

Learn effective counseling strategies for individuals with chronic fatigue syndrome to encourage safe exercise.

“harder to do when you have to sort of look at monitoring only directly after the session or during the session.”
Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:00Jordan Feigenbaum:This month, we're tackling a study that went around claiming that the longevity benefit of lifting weights disappears once you train more than one hour per week. It's a real paper in a real journal, and the claim is wrong. We'll walk through why. We'll also get into whether a GLP-1 flattens your mood and your motivation along with your appetite. Same calories, more weight loss argument that will not die, and what you can actually do in the gym when you have chronic fatigue syndrome. I'm Dr. Jordan Feigenbaum, and this is the Barbell Medicine Podcast.

0:37Jordan Feigenbaum:All right, well, let's get into this first one. This is about lifting weights for more than one hour per week. The question is, the paper by MoMA et al says that the longevity benefit of lifting weights disappears once you get past about 60 minutes a week of training. This seems unlikely to me. I think we share your skepticism, but let's talk about why. I think that the 60 minutes thing, we need to walk through the whole study because it did become a headline for a while. This came out in 2022, it was published in the British Journal of Sports Medicine by MoMA and colleagues. They took 16 prospective cohort studies together and looked at whether lifting on its own is tied to living longer and how that changes with how much lifting you do.

1:24Jordan Feigenbaum:let's start with some good news any strength training versus none unsurprisingly uh improves uh things like mortality in this particular review was a 15 percent lower all-cause mortality i think there was another one that showed like a 23 percent one from dankel um basically if you met the the muscle strengthening guidelines um if you do lifting and cardio together this particular review uh showed that that reduction in all-cause mortality uh dropped by about 40 percent now Now, the problem here is there's like a dose response curve where in this particular group of studies, it showed that the more lifting that they did, the improvement or the reduction mortality, it sort of started to drift back towards neutral.

2:10Jordan Feigenbaum:It never crossed the threshold showing it was harmful, but just the benefit wasn't proportional to the amount of exercise that they were doing. now some people might interpret that and say well look if the improvement is reducing then lifting more is is is bad other people might view that in a way i kind of looked at it was like well how many people are actually doing a bunch of lifting and here and when you look at the actual study there's just not that many people that were doing a bunch of lifting and further the sort of protective benefits never went back the other way showing showing harm so with nobody in these cohorts in this study really doing high lifting volumes.

2:49Jordan Feigenbaum:And further, the way they collected this data was at the beginning of the study, you just kind of self-reported how much lifting that you were doing. And then they followed these people. Now, I'm not saying this is a terrible study design. It's just, we got to know the limitations of the study. It's just messy here at high volumes. The one thing that I kind of take away from this is that any lifting beats nothing. I don't know that that's surprising to anyone, but the magnitude of benefit I think is surprising. if if you know you talk to somebody who wasn't doing any lifting and he said look just doing a little bit has this potential to do uh have a big benefit i don't know that that motivates them to start lifting but it certainly uh certainly could be an interesting fodder for discussion there's a newer longer study that actually came out of harvard uh this year by zhang followed about 147 000 people up to 30 years and re-measured their training as they went along rather than just asking a questionnaire at the beginning, the benefit actually spread, went up to two hours.

3:44Jordan Feigenbaum:Now there was a continued sort of dose response relationship up to two hours. Now, again, that doesn't mean lifting for more than two hours per week is necessarily harmful. There's just not that many people up there. And further, you get a lot of confounders, you know, as when we do this sort of, sort of analysis. But I think overall our heuristic, and Austin, you can, you can correct me if I'm wrong, or maybe overstating it. We still think there's this dose response relationship between exercise, generally speaking, and benefit. Where that shakes out for resistance training is probably lower than most of what our listeners would want to hear, right?

4:18Jordan Feigenbaum:Because they're like, I just wanna lift, you know, four times a week, five times a week. And we're like, for health benefits, it probably plateaus, you know, right around, maybe double the current physical activity guidelines for health benefit, maybe even a little lower. But for conditioning, that benefit keeps kind of tracking on, um you know there's some benefit from continued more and more increased volumes of exercise is that kind of square with with what you're you're you think about like the sort of dose response

4:44Austin Baraki:relationship sort of although there are things that even that claim leaves out here and that's part of why this type of study doesn't really get me terribly interested or excited or impact what i recommend to somebody it's just like i think you said that you weren't uh you weren't wanting to call this a terrible study design. I tend to not use inflammatory language like that in general, but I'm not pleased with, you know, the choice of metric here in particularly like time of resistance training. It's like, if somebody tells me I strength trained for 30 minutes or 60 minutes or two hours or four hours, I still don't particularly know what you did.

5:23Austin Baraki:And I don't know whether it was appropriate for your level of adaptation. Um, I don't know what you're counting as resistance training. I don't know any of the other like variables to determine was this like a reasonable strength training program in general and was a reasonable match for you and your level of adaptation and your goals. And so, you know, when you say that maybe it plateaus at double the guidelines, that still, you know, leaves out what is the actual outcome that the person is achieving. Because you've made this case before, is that yeah, participating is beneficial, but actually getting the adaptations is the thing that is best you know kind of correlated to the the health impacts if you were doing a strength training program that is in fact making you stronger right and so then that brings into the equation well is the amount of training that you do how does that relate to the outcomes that you get and that is what is going to be different for everybody some people need you know to do more per week to get a you know incremental additional adaptation whereas others the freaks among us the very training sensitive the closer to beginner territory can make substantial progress on relatively little training so there's multiple additional layers to this that make this study and any sort of claims that emerge from it in terms of oh if you you know train up to this many minutes per week it's beneficial beyond that it's not no longer beneficial i find that not only in unconvincing but actually pretty implausible Now, if I'm translating this to like a clinical scenario where I'm sitting in front of a patient doing some exercise counseling, you could frame this as if I was talking to them about whichever, whether they're strength training or they're cardiorespiratory, they're aerobic training, and they're currently doing nothing.

7:09Austin Baraki:How strong of a case can I make for getting them from doing nothing to doing 30 minutes a week? A very, very, very strong case. From there, how strong of a case can I make for getting them from doing, say, 30 or 60 minutes up to 60 to 90 minutes or two hours a week. I can still make a pretty good case for that, right? If they're already doing two hours a week of say strength training, how much stronger of a case can I make for them pushing it to three hours, to four hours? I think it is fairly obvious to most people that purely from a health standpoint, the strength of my case is going to diminish for health outcomes.

7:46Austin Baraki:Now, if the person says, look, I have made a lot of progress so far, but my progress in strength adaptations, in muscle gain is really starting to taper off, that's where I now suddenly have a stronger case of, yeah, we could probably be doing more, be doing things differently, but that's not really a conversation that's happening as much in the clinical realm. That's more a conversation that's happening in like the coaching sort of realm for people who are highly motivated for those particular adaptive outcomes. But for people who I'm working with who are either for general health purposes, who have cardiovascular conditions that are just trying to get healthier, who are on GLP-1 medicines, trying to maintain their strength and muscle.

8:21Austin Baraki:Again, that strongest case that I can make, yeah, is for the initial bit. And that case weakens the larger of volumes we're talking about, unless the person has very particular performance goals or if they just want to. But I'm not telling them if they say I want to, that like, oh, don't go over this many minutes because you're gonna like, you know, die sooner or compromise your longevity, you know, gains from this kind of thing. I just do not buy it. And I would not use a study that looked at mainly time time without, again, a sense of what is the actual program look like, which is kind of hard to do in most of these types of studies because everybody's doing different stuff.

9:00Austin Baraki:Who knows what their programs are coming from? Who knows what the actual level of intensity is that the person, it's just too messy, right? And so this is fundamentally like useless for me in like clinical decision making and like guidelines, I would say.

9:13Jordan Feigenbaum:Yeah. Yeah. What you would want from like a research, you know, approach for this is like some way to grade the exercise and to take heterogeneous programs, different programs, and then distill them down to a number that actually represents the training load on some level. Some kind of strength training stress index or something like that. Yes, which I've been working on for a long time. Yeah. And further, the sort of metrics it's associated with, because to your point, the thing isn't just like how much training the people are doing. It's really what is their response because effectively what you would want a study like this to tell you clinically is that look, by achieving X outcome, here is the risk reduction, right?

9:54Jordan Feigenbaum:So that whether that's strength, whether it's power, whether it's cardiorespiratory fitness, these are all things that can be tested. And so you'd want to say, look, by achieving this particular level of strength, power, cardiorespiratory fitness, you maximize your benefit or right. And at that, and then after which with this study, maybe the headline was insinuating is that, well, once you go past the certain amount, maybe, maybe not so good, which we have not seen. We have not seen that for strength where it says, look, the strongest quartile or tertile or however you would split up, you know, various sort of, you know, strength categories has like worse outcomes.

10:28Jordan Feigenbaum:Never, never, never seen that. So yeah, I would want an exercise program to generate the outcomes that we want and then measure those against, you know, if that's a performance outcome, how does that stack up against the health outcome. And then we'd have a better answer. But overall, I think our general heuristic is that generally speaking, generally speaking, more exercise, more better for health and certainly for fitness, where you sort of kind of get diminishing returns, I think changes for each particular health or sorry, fitness adaptation, strength, power, cardiovascular fitness, I think it's higher for cardiovascular fitness, that ceiling lower for strength and power.

11:07Jordan Feigenbaum:But I don't think i could convince somebody to do less strength training because i think it's harmful for them the only way that i could rationalize it being harmful is if it is likely to drive injury and subsequent decrease in activity or someone's doing so much resistance training that they're effectively unable to do any conditioning because they have no time right but i don't think

11:26Austin Baraki:that's really what these studies are pointing at yeah i think that's a fair framing and this reminds me of i got a consult question from from a patient recently who brought up the question of basically are there any strategies to mitigate the downsides of you know strength training for example on the cardiovascular system i'm like what downsides and then they shared with me some resources that they had found they had used some some ai tools some searching to find some evidence but what was coming back was all of the evidence in something we talked about way back 150 podcast episodes ago in the extreme exercise hypothesis on ultra endurance uh sort of training and the increased or the association or increased risk of things like atrial fibrillation, coronary artery calcification, things like that.

12:10Austin Baraki:And I was like, all of this is in ultra endurance, ultra high volume and high intensity aerobic, you know, sort of stuff. Not to demonize that or to say that that's necessarily bad for longevity. There are certainly trade-offs, but that is like when you're getting at very, very, very high volumes and high intensities of ultra endurance sort of activity, not applicable to strength training, is not a thing that is observed where, for example, if you do you know too many sets per week of uh deadlifts or something that you're going to be at markedly higher risk of developing you know atrial fibrillation or something like that that's like not a thing that's ever been shown so good news not something you need to worry about and the vast overwhelming majority of people are not in fact uh you know meeting those kind of thresholds for what would be considered you know sufficiently ultra endurance level volumes of activity that would be conferring some degree of risk and the people who are are most often consciously choosing that because they love to do that.

13:02Yeah.

13:03Jordan Feigenbaum:Yeah. I think the biggest risk from doing too much exercise, it happens to be musculoskeletal injury. And then, you know, you could go even further into your point, very consciously choosing to do a lot, a lot of conditioning exercise. Sure. Increased risk of atrial fibrillation, which can be managed. And ultimately those people aren't dying any sooner either. It's just like, yeah, no biological free lunches here. So this podcast is brought to you buy ButcherBox. One thing I try to stay consistent with is keeping enough protein in the house so I don't end up ordering takeout a few times a week.

13:35Jordan Feigenbaum:That sounds simple, but between work and everything else, the grocery store trip is usually the first thing that gets cut. ButcherBox fixed that for me. They deliver grass-fed beef, organic chicken, wild-caught seafood, and more, all sourced to the standards they are transparent about. Every box is customizable, so you pick the cuts and the proteins that fit how you actually cook and what you're actually going to eat. It's like having a butcher on call who already did the sourcing homework for you. And let me just tell you, the quality is legit. I've been grilling a lot lately. It's summer here in San Diego, and the meat has been excellent.

14:05Jordan Feigenbaum:It tastes great. It shows up right to my door, exactly what I want. And I don't have to think about it. I don't have to make a trip. That's the whole point. It's an easy button for your food. Now, whether you're grilling on the weekend, meal prepping for the week, or just trying to get a real dinner on the table on a Tuesday, you've already got something good in the freezer ready to go. Go to butcherbox.com slash barbell to get$20 off your first box, plus your choice of free ground beef for life, or free chicken thighs or top sirloins in every box for a year with free shipping always. That's butcherbox.com slash barbell, B-A-R-B-E-L-L.

14:38Jordan Feigenbaum:Be sure to use our link so they know that we sent you. This podcast is brought to you by Factor. The last few months have been a real time crunch for me. I've been finishing the book Signal, and between that, training, and everything else I've been doing, cooking has been a real challenge. And Factor has been the thing keeping my nutrition from going by the wayside. Having meals ready to go that I can heat up in two minutes and actually feel good about eating has made a real difference on the days where I just don't have those 30 minutes to stand in the kitchen, especially when it's late at night.

15:04Jordan Feigenbaum:Bactor meals are chef-crafted and dietician-designed. They're ready to eat with no prep and no cleanup. They have over 100 menu items rotating every week, including new options like salmon burgers, shredded pork, and collard greens, plus add-ons like protein shakes and pumpkin cheesecake. Over 175 banned ingredients, so the stuff that you probably don't want in your food isn't going to be there either. I use Factor and I bet you could benefit from it too, especially if your schedule gets tight. Food is usually the first thing that slips. This keeps that from happening. Head over to factormeals.com slash BBM50off and use code BBM50off to get 50 % off and one free breakfast item per box for a year while supplies last until October 31st, 2026.

15:43Jordan Feigenbaum:That's code BBM50off at factormeals.com. Again, BBM50off at factormeals.com. See the website for more details. This podcast is brought to you by Quince. End of summer is when I start thinking about what I actually want in my closet for the next few months. You know, not a full overhaul, just swapping out the stuff that's worn out and filling in some gaps. And that's what keeps bringing me back to Quince. They do everyday staples really well. Their organic cotton tees are soft and hold up wash after wash. Their cashmere sweaters are legitimately good for the price point. And they transition straight into fall.

16:14Jordan Feigenbaum:If you need pants, their premium denim and tailored chinos start at just$60. And the fit and fabric are on par with brands charging three or four times that. Ask me how I know. Now, everything at Quince is priced 50 to 80 % less than similar brands because they work directly with the factories and skip the middlemen. You are paying for the materials and the construction, not a logo or marketing campaign. Now, one of my go-tos this summer has been their organic cotton mesh stitch sweater polos. I have it in almost every color. And it's one of those pieces where you look put together, but you're actually comfortable, which is why these are going to stay in my rotation for the fall.

16:46Jordan Feigenbaum:And Quince goes way beyond just clothing. They've got premium bedding, bath essentials, cookware, travel gear. It's one of those brands where you buy one thing and end up recommending it to everyone. Both Lee and I have their sheets and they're great. So upgrade your every day. Download the Quince app for app-exclusive offers or go to quince.com slash BBM. Get free shipping on your order and 365-day returns. Now available in Canada and the UK too. That's quince.com slash BBM. This podcast is brought to you by Figs. If you're in healthcare or you're in training for it, back-to-school season means you're about to spend a lot of time in scrubs.

17:19Jordan Feigenbaum:and figs just drop new colors and back-to-school styles. And right now, everything on their site is 20 % off. During my medical training, I found out that the standard hospital scrubs were not designed for anyone squatting, period. Bending over to examine a patient was like a truss fall, just hoping that the seam would hold. That's how I ended up trying figs. They're cut with actual stretch, they fit like real clothes, and they survived both the job and the squat program. They're also antimicrobial and they hold up to the laundry abuse that this job requires. They also have footwear, compression socks, and outerwear.

17:48Jordan Feigenbaum:And 20 % off site-wide is the best deal they run. So if you've been meaning to replace your scrubs or stock up for a new rotation, this is the time. Go to wearfigs.com, get 20 % off everything through August 11th. No codes needed. That's wearfigs.com. Hey, it's Jordan here. This is an ad for a subscription that removes ads, including this one, which is a good way that you never have to hear this again. And you can do that by signing up for Barbell Medicine Plus, which is now 25 % off annually through August 13th with the code PLUSANNUAL. annual. Now the ad free listening feed means this exact minute of your life, you'll never have to do this again.

18:23Jordan Feigenbaum:You also get member only AMAs with Austin and I plus bonus episodes, early access to our content articles, and more. Plus you get discounts on training templates, 10 % off 15 % off consults, 25 % off courses and seminars plus member only sales. If you're going to buy any of that stuff anyway, you now have solved the ad problem by shopping, which is not how I thought this was going to play out, but mostly it's how people support the show and that support is the reason it keeps going. So sign up for Barbell Medicine Plus, use code PLUS annual through August 13th. This has been an ad about itself.

18:58Jordan Feigenbaum:Now back to the show. All right, next question is on GLP-1s. Will we ever sufficiently talk about GLP-1s such that all of the questions have been answered? Me thinks no. So this question is, I'm probably going to try GLP-1. My main concern is psychiatric. Does the quote hedonic stuff that these act on only affect appetite? I enjoy gaming with friends and other things that you'd call hedonic, including libido. Have you noticed GLP-1s affecting people's motivation to do stuff, not counting eating, or their mood going down? So he knows the appetite affects cold. He wants to know if the drug will dull his mood, his drive, his enjoyment of everything else.

19:37Jordan Feigenbaum:To me, there are three pieces to this. One is reassuring. One we genuinely don't know. And one he hasn't, he isn't really asking about. The first is reassuring to me. It's the mood on average holds or get, gets a little better. Now there was some thought that maybe there was an increased risk of depression. Maybe there was an increased risk of suicidal ideation, for example, that was like some preliminary data coming out. But when those data has, have been reanalyzed and taken to their conclusion, the best control data coming out of the step trials in people without major psychiatric illness found depression scores a touch better on average with some agglutide than placebo.

20:17Jordan Feigenbaum:Now, whether this is clinically meaningful or not, that's up for up for debate. The authors said no, but it doesn't show like, look, higher increased risks of depression, even though there was maybe a thought that that could happen. Suicidal ideation is the same. It's the same story on that. There was a scare that has been walked back in early 2026. The FDA asked for the suicidal ideation wanting to be removed after reviewing 91 placebo-controlled trials covering about 108 ,000 patients, plus over 2 million real-world users, and the European regulatory body landed in the same place. So this Ozempic makes you depressed sort of claim, yeah, we can kind of nip that in the bud.

20:56Jordan Feigenbaum:The second piece to me is less clear, and before I get into it, I want to tag you in, Austin, since you're the one actually prescribing these. When a patient is on one of these and you check in, do they ever describe anything past like the appetite change, something with their drive, mood, or wanting things less across the board? What have you actually seen?

21:15Austin Baraki:I will say a few things because this is a fairly common concern and conversation that I have with folks. So yes, I have seen some of these things. No, it is not the most common response to these medicines. So some good news for this person is that it is not typical for patients who are starting these medicines, particularly when properly dosed, and properly dosed means always starting at the lowest dose of the medicine for them to experience this. More often when I have seen more of this kind of suppression of mood, of interest, of motivation, it tends to arise at the highest doses and more often with ZEP bound than with Wigovi or semaglutide.

21:57Austin Baraki:semaglutide. There's some thought and conversation in this space of, is there some contribution of the GIP element to that? I'm not going to get into the details of that neurobiology just yet, but that's kind of part of the conversation. The other things are that even that in that situation, it is frequently manageable. So a lot of the time, what I end up doing with these folks is lowering their dose. So say somebody's on 15 milligrams of trisepatide or ZepBound, which is the highest dose which takes many months to get up to that dose just to be clear and you have a lot of opportunity and time along the way to notice how you're feeling to not continue increasing to go back down to adjust your dosing strategy but let's say you get up to 10 to 12 to 15 milligrams and you're experiencing something like this then oftentimes i'll drop them down maybe by five milligrams or so from 15 say down to 10 see how they do sometimes we can augment their therapy combine it with another tool like bupropion which is a medicine that can have some kind of activating type effects can improve some of this motivation, this energy, this drive.

22:58Austin Baraki:And I've had actually really quite good success in using this strategy with most of the patients that I have who have experienced this. But again, the big picture caveat that I want to kind of reemphasize here and illustrate is that this is not a typical or a very, very common concern or effect that I'm observing in most patients using these medicines. It affects a small minority. And of that minority, it tends to be at the highest doses. The reason why that's good news for you is, well, if it's affecting the minority, you are unlikely to be affected. If you are, nothing about starting these medicines is a permanent effect.

23:32Austin Baraki:If you notice something that you don't like, talk with your prescribing clinician. They should ideally know how to handle this. If not, I do. We can get sometimes creative with dosing strategies and try other agents and other options. And you can also stop at any time. And that's not actually a problem either. I have lots of patients who have existing psychiatric conditions, some of them having actually quite severe psychiatric issues, things like, you know, bipolar disorder, you know, things like that that are on actually fairly intensive psychiatric mental health medications, some with prior history of very severe depression with suicidality with hospitalizations who are actually doing fine on these medicines, you know, again, with with monitoring and things like that over time.

24:14Austin Baraki:but it's this is not a concern that i want to kind of blow out of proportion in terms of what i'm observing in real life using this with like lots and lots and lots of people yeah yeah i think

Read the full transcript

24:24Jordan Feigenbaum:you know when the mechanism was kind of sussed out a little bit look these drugs act on the brains reward pathway this sort of wiring that creates the urge to want to do something um with less payoff than you would otherwise expect you know then people are like could this be useful or researchers certainly were like, could this be useful for substance abuse? Right. Which on the one hand was like a silver lining. And then other people took that to like, to, to suggest, well, maybe I won't like anything. And there's been some effect, you know, people reporting like flat effect and stuff like that.

24:54Jordan Feigenbaum:Um, there's some interesting data here. You know, researchers have investigated what happens if you give people with alcohol use disorder, a GLP one and see what happens. Well, they, they drink less, uh, for example. Um, so there's a study came out last Last year in JAMA psychiatry, 48 people with alcohol use disorder. They were on low dose semaglutide, so ozempic we go V, or placebo. And they were put in a bar lab, which, can I go? Like it's just a simulated drinking environment. In any case, it cut how much they drank and they craved. And they also cut their cigarette consumption as well. There's a second trial recently published in the Lancet, which was bigger and longer and showed the same thing.

25:36Jordan Feigenbaum:Now, this has never been studied for like gaming. Right. It's never been studied for socializing other hobbies or whatever. So all of like the brain imaging studies and the mechanisms hasn't really been applied here. We do think that these sort of if you want to call them an anti reward type effect, we do think that it reaches past food, but we don't know to what extent. And the hobbies, you know, in this case are pretty much untested. So that's an open question. um yeah sure a few people like as you mentioned a minority can report feeling flat but that's more anecdote than anything else and i don't think there's a huge signal otherwise showing like a lot of people experience this and it's a big problem i would be concerned if there was a big libido effect uh but i suspect if anything it would probably get better mainly because the effect of the drug itself like if you if someone's appropriately prescribed these medications they are carrying excess body fat.

26:31Jordan Feigenbaum:And, you know, in men who are carrying extra body fat, that tends to reduce testosterone, particularly if they have a high amount of visceral adipose tissue, again, surrounding your internal organs. And because these drugs do such a good job at reducing that, testosterone levels actually tend to go up. Now, libido itself is more complex than just testosterone level, but we do think that this would likely improve. I think you can see sort of a confounder though if people are not eating enough generally speaking and they're losing weight very quickly so that fatigue can sort of overwhelm any sort of hormonally mediated improvement in libido but that's like a kind of separate issue but the third question and the one that i think uh uh you know needs to be asked whenever we discuss these sorts of things mainly due to the still fairly prohibitive cost where are people getting these medications from so if somebody's sourcing a GLP-1 through like research chemical or gray, you know, gray market sort of peptide.

27:30Jordan Feigenbaum:I have concerns about that. Maybe not just related to like anhedonia, right? Or like reduced enjoyment of activities, but mostly just like safety, because you don't really know the dose that you're getting. For example, you don't really know if what is marked, you know, labeled on the vials, what you're actually getting. Plus, if you're getting it through those sources, I do wonder about the monitoring. So all of that sort of kind of tilts the risk benefit scale firmly, to me at least, towards the risk sort of situation. But I think overall, the psychiatric risk is relatively low, if anything, likely to be beneficial, as long as somebody's not really taking an unregulated peptide from the gray market here.

28:09So Austin,

28:10Jordan Feigenbaum:you've got patients on these medications. Now, if this individual was your patient, acknowledging this is not medical advice, this is for infotainment purposes only, and they're kind of express these concerns about anhedonia having a sort of flat effect. How would you counsel him on that? Would it be mostly like, hey, we're going to monitor this as we go along? We're starting low, this is minority or anything unique in your sort of counseling here?

28:34Austin Baraki:Yeah, I want to first be clear about what is the goal of therapy? Because one of the things that wasn't listed in the question is like, what is the indication for using a GLP-1 medicine in this situation? Is this somebody with obesity, with metabolic disease, with cardiovascular disease, with fatty liver disease, with chronic kidney disease? All of those things or any combination of them really strengthens the case for benefit outweighing potential risk. That's the first thing. Now, if on the other hand, he says, I'm super lean, jacked, healthy, I'm wanting to use a GLP-1 weather prescription, FDA approved, or gray market, red up, so I can prep for a bodybuilding show.

29:09Austin Baraki:I'm not saying he's saying this, or she is saying this, but that obviously changes the potential benefit to potential risk sort of calculation there. Right. That's that's the first thing, because we're always framing these therapeutic conversations around what are the potential benefits that we are looking for? What is the goal and what are the potential downsides that we should be aware of and kind of take into account? And then once accounting for those things, can we negotiate a mutually acceptable strategy to navigate that path together? And so if this person has clear clinical indications for their use or that if they don't, they are willing to accept potential downsides despite the lack of a clinical indication for its use, then yes, the plan would be, hey, we're going to start at the lowest dose.

29:55Austin Baraki:We will monitor how you're doing, knowing that we have creative dosing strategies, options for combination therapies to address side effects if needed, or we can always go back down in dose, or we can stop and it is a reversible effect, not something that tends to be permanent. And again, I would reiterate that the big picture of observation in practice is that this is infrequent. If it happens, more often at the highest doses that take a while to get to, and it's something that we can mitigate gate by just going back down. And so that that flexibility is quite quite nice about these agents. Yeah.

30:29Jordan Feigenbaum:All right. Well, that's about as new as medicine gets. Now let's tackle one of the oldest questions in the field. Is a calorie really just a calorie? So the question is, can you discuss the nuance around the studies showing weight loss when protein goes up, even at the same or higher calories? There's one you energetic that just means at the same calorie level. There's one you energetic high protein trial in particular. I've also heard people say keto lets them eat more and still lose weight. Yeah. So on its face that, you know, these two scenarios look like they break physics, you know, you're eating more calories, presumably, and still losing weight.

31:06Jordan Feigenbaum:Uh, but if you dig in, it's kind of, uh, it's kind of a farce. Okay. So let's, let's start with the, we'll back up a little bit and start with the phrase that everyone kind of fights about. Is a calorie really a calorie? Just a calorie? Yeah, it is 100 % of the time a calorie is just a calorie because it's a unit, just like a second or a meter or, you know, measures time or distance. A calorie is a unit of measure for energy. um that said you know calories in calories out is a calorie just a calorie i think what people are getting at when they're i mean trying to poke holes in that relationship is that on either side calories in calories out both sides are dynamic and just stating the relationship is not terribly helpful advice for most folks and i think that's fine two things can be true a calorie can just be a calorie but the advice to just eat less move more or it's all just about energy balance may not be great advice.

31:59Jordan Feigenbaum:And I think that's fine. Now with respect to protein, I think it's fair to say that protein pushes both the calories in and calories out. It affects them both in a way that favors weight loss. I think it's fair to say that, but there's some nuance here because effectively the effects are modest. So when you increase dietary protein intake, a few things happen. One, it tends to displace other foods. You know, Americans typically eat quite a lot of protein, about one, 1.1 grams of protein per kilogram body weight per day. But most of that protein is from ultra processed or highly processed sources, tends to have a lot of fat and other things, which increases energy intake.

32:43Jordan Feigenbaum:And so when people make this, quote, conscious choice to eat more lean protein in particular, it can displace some of those higher calorie options and other options that don't have a lot of protein but otherwise do contain a lot of calories so that could reduce energy intake for example increasing dietary protein intake also tends to increase the thermic effect of food because protein costs more to digest than carbs or fat but it's mostly a small effect if any we know that yeah it does take more energy to break down protein but how that affects total daily energy expenditure we don't really know because everything kind of is dynamic.

33:19Jordan Feigenbaum:When you increase one variable that, you know, the system isn't closed, everything else changes too. So I don't know that increasing dietary protein actually increases calorie burn in a way that produces weight loss. I think the main factor here is it reduces intake overall. So the study that was sent here is from 2020, Haggiat in British Journal of Nutrition, it was 12 weeks. And basically they looked at the effect of a high protein diet versus So a standard protein diet in women. Now, the diets that were prescribed to these individuals were the same in calories. There was the prescription, which differs from how they were actually implemented because they actually ate different levels of calories.

33:59Jordan Feigenbaum:In the study, in table one, the high protein group reported that their intake fell over the trial while the standard protein groups actually held the same. So the average in the high protein group, they ate about 90 fewer calories per day, closer to 130 fewer calories by the end of the trial. They also cut carbohydrates, which drags water and glycogen out. And so they were eating less calories. And what do you predict happens when people do that? Well, they lose weight. There was an improvement in body composition here showing increase in lean body mass, decrease in fat mass, unique to the high protein group, which isn't a surprising finding when it's combined with resistance training but it was surprising in this study so you have to look a little deeper and you look in the methodology and how did they assess body composition bioelectrical impedance which is pretty poor a bathroom grade device if i'm being charitable the authors themselves say look this wasn't a gold standard and which begs the question like what why did we use this for that it just is not sensitive enough to discern relatively small changes in lean body mass.

35:06Jordan Feigenbaum:And, you know, in the defense of BIA, bioelectrical impedance, DEXA wouldn't be good either in this short period of time, mainly because you just need large changes in actual muscle tissue and fat mass for it to be picked up on either one of these tests. Bioelectrical impedance is just worse, right? So ultimately the people in the high protein diet ate less, so they lost more weight. and the body composition changes in this relatively short study were mostly a result of a measurement error although again i would expect a higher protein diet up to a certain level probably about 1.6 1.8 grams of protein per kilogram body weight per day to improve lean lean mass if people were resistance training although if people weren't resistance training i don't really think it's going to move much for muscle mass to me the keto version uh dies the same death you know when people say they went keto and they ate more and lost weight, really what happened is they felt like they were eating more, but actually their calorie intake went down.

36:00Jordan Feigenbaum:This has been investigated. You know, people said, hey, you can only eat these types of foods, in this case, a ketogenic diet, and they tend to eat less some of the time. What's more interesting to me about the ketogenic diet data is that that is a relatively short-term effect. When you look at six months, one year, the weight loss, quote, advantage disappears relative to other types of diets. Now, if somebody wanted to follow a ketogenic diet in perpetuity, they hate carbs, war on carbs. Okay. There are ways to do that. That's fine. And that's ultimately fits their preferences, allows them to eat the correct amount of energy.

36:35Jordan Feigenbaum:But the idea that ketogenic diet somehow breaks the law of physics where people can eat more calories and lose weight has never been shown. Never been shown. So Austin, how do you handle this? When a patient swears they're eating more and losing weight, or they're losing on keto without counting their calories. What does the conversation look like? I'm going to kind of guess. You say, nice. But I'm very curious how you address this.

37:04Austin Baraki:Yeah, firstly, it would be nice. Cool. Keep it up. That's great. I think that the other aspect of this conversation, though, is definitely wanting to be on the same team with the patient. And that means that if the ultimate goal of this is for their health, then yes, as long as they are making progress, losing in a way that they prefer, then yes, I'm on their team for that. But I also wanna make sure that they are on my team in the sense of, hey, we wanna make sure there's not detrimental effects happening from this diet. And so the reason I bring that up is depending on the particular food choices, the way that this keto diet is set up, there can be, even if you're losing weight, can be some other detrimental effects.

37:41Austin Baraki:For example, if you are consuming very high amounts of animal-derived saturated fats, as we've talked about many times before, that can have some detrimental effects on your blood lipid profile, for example. There might be some other impacts that are adverse on your insulin sensitivity and things like that. So I definitely wanna make sure, hey, we wanna make sure you're very sufficiently active. And if I can get them to agree that we should aim to make the most progress we can while avoiding objectively detrimental effects, then we can say, hey, if we see that, like say your blood lipid panel goes haywire, like your LDL goes up, your triglycerides go up, your things like that, that would you be open to making some, you know, tweaks, some modifications to this keto diet within the realm of your preferences as much as possible to mitigate that.

38:28Austin Baraki:And I think that there's likely to be a way to, you know, thread that needle. Maybe we swap out some of the, you know, dietary fat sources for more unsaturated sources from, you know, seafood sources, from plant derived sources, things like that. And then aiming to get the dietary fiber intake up to our standard recommended targets for whichever population the patient falls in. So typically, getting them up to say 30, 40 grams of fiber a day, if they're willing to go that high or as high as they're willing to go within the confines of their diet. And then that might confer some beneficial effects on those otherwise detrimental effects.

39:02Austin Baraki:So I think that that's the two big pieces is making sure that we are getting the benefits we're looking for and mitigating the harms. If we can do those two things and the person wants to stay keto, like we go for it.

39:14Jordan Feigenbaum:yeah yeah and further if somebody was like i want to increase my dietary protein and you know what what can i expect what to expect when you're expecting it's like well it depends where you're starting at right now so for example if a person's consuming you know 0.6 to 0.8 grams of protein per kilogram body weight per day and they're like i'm gonna go up to 1.6 i'm like okay well provided that your resistance training right i suspect you're gonna have uh get you know a bigger benefit from your exercise i do suspect that that increase in protein is going to displace other higher calorie foods from your plate.

39:46Jordan Feigenbaum:And so net, I would expect some benefit now going from like 1.6 to 2.2 or, or more. I don't expect that benefit. On the other hand, it could further displace other foods from, from your plate. And so some people may find that approach successful in the short term, but long-term that has not been borne out either, where it's just like, no, just jack your protein up and you're going to lose more weight. It's like, well, at the end of the day, it all comes down to energy balance one way or another. but I think overall you and I are aligned we're not calling this person a liar and and and breaking out the physics for them and saying well look the law of thermodynamics yeah there was no point just like telling people to eat less and move more that is not particularly useful advice telling people that it all comes down to energy balance is probably also not useful advice all right our next question has to do with lifting and chronic fatigue syndrome the question is what's the best weightlifting to do when you have chronic fatigue syndrome?

40:40Jordan Feigenbaum:I go weeks where I barely have the energy to shower. I want to increase my lifting. I sometimes lift weights in bed on my worst days, but my boyfriend says that isn't doing anything. What are some exercises that won't make me need to sleep for two days? All right. So some people are going to say, look, chronic fatigue syndrome, this is made up. It's not a real illness, but it is. And it's often referred to as myalgic encephalomyelitis or MECFS. And in 2015, there was a National Academies of Science panel that laid out formal criteria for diagnosing it. Now, the thing that separates it from just being quote tired is what happens after somebody exerts themselves.

41:20Jordan Feigenbaum:So in this particular instance, she does something, whether it's physical or mental, and instead of being wiped out that same day or being tired that same day, there's a sort of extended sort of crash for multiple days, in some cases, even longer than that. And it's out of proportion to the effort that was it was done. Now, her question says it plainly, basically doing some light lifting, and then I need to sleep for two days. That sort of delayed crash is called post exertional malaise. And it's one of the key features of this particular condition. There's a really interesting case with a pair of identical twins where one has chronic fatigue syndrome, and the other doesn't.

41:55Jordan Feigenbaum:Same genes raised together, so you can't chalk it up to genetics or lifestyle. Now both did a hard exercise test two days in a row. The healthy twin repeated their performance on day two just fine. The twin, though, with chronic fatigue syndrome, dropped about 13 % at the anaerobic threshold test on the second day, basically the point where the effort tips from manageable to much harder. And it's not just a twin curiosity. Run the same two-day test on groups of these patients and the same pattern holds. They show a bigger drop off on day two than healthy people do. You can't really talk yourself out of that.

42:27Jordan Feigenbaum:Unfortunately, there's no real proven program or like exercise routine for this. It hasn't been studied well. And but the one thing that everyone agrees on is basically staying under the sort of limit that sets off a crash. Now, this is a relatively new update, because for a long time, the idea was, look, we just got to push these patients. We just have to like tell them just add a little bit more every week to sort of graded exercise. Unfortunately, that just is like forced progression. And it turned out to be wrong. Now, it's also wrong in others like people without this condition. But that seems to be a little bit more again, disruptive in this in this population.

43:04Jordan Feigenbaum:And there's just lower stakes. If you kind of overdo it in a healthy person, they're like, man, I'm sore for longer, I'm tired for longer, my performance has decreased, but they bounce back relatively quickly, usually, these, these folks can be prolonged. so the guidance has flipped and this happened uh you know in in the last few few years as far as her boyfriend goes he's half right look lifting weights in bed is probably not going to build as much muscle or strength as like going to a gym and doing a quote real training session but that's not really the point it's better than doing nothing thing one and two she's getting something out of it for exercise to really accomplish nothing it has to be so submaximal so light so easy that it does not challenge her or the person at any level, which is pretty hard to do.

43:51Jordan Feigenbaum:You got to, you'd have to like really fabricate something, um, you know, uh, something unnatural, uh, for, for that to happen. Um, ultimately to me, this is like doing what you can, when you can, where you can. And I think that's certainly better than nothing. So the way I would approach this from a practical perspective, I generally think that shorter bouts of exercise are likely a better place to start then longer ones and would do longer rests so instead of having like six exercises on the docket maybe you only have two right and instead of resting you know only two to four minutes maybe it's four to six minutes which you can get away with if you only have two exercises for example i would also generally stick with lower rpe targets you know probably more five six compared to six seven or eight i would also instead of trying to force progression with a fixed rep range, for example, use double progression, wherein you would have a rep range of like six to 10 reps, for example, and only add weight when you could max out all of the sets at 10 reps at a given load.

44:50Jordan Feigenbaum:And so it's going to be a little bit more of a gradual progression, delayed progression that we're sort of constraining with that, that rep range. I would also have a backup plan. If, for example, someone is feeling like, I don't really have it today, you know, not just like, I feel sore, if I don't feel quite as strong as normal, in this case, like my energy levels are really, really low, maybe all they can do are isometrics, you know, where you're creating force and not really moving dynamically, or maybe it's just much lighter. And then the other thing that would add that's kind of unique here, we often talk about monitoring session RP, like how hard was the effort, you know, what was the whole training session, whereas a session RP 10 would be like, that's maximal, it's the most thing, most I've ever done.

45:29Jordan Feigenbaum:And SRPE one is like, that was rest, I didn't do anything. Yeah, we should measure that, right. But also, I'd want to see what happens the next day and two days later and three days later because the sort of disruption and prolonged sort of decrease uh in energy level uh sometimes called an energy envelope happens days later and so you would really want to have you know be kind of like monitoring this post hoc just to see like is the program that we're on right now is it adjustable enough and is it like actually like uh meeting the person where they're at you know and i think that it's harder to do when you have to sort of look at monitoring only directly after the session or during the session.

46:10Jordan Feigenbaum:So it needs to be a little bit longer than that. So Austin, this is where you're better than any study. If this were your patient, someone with chronic fatigue syndrome, who actually wants to lift and is scared of the crash they've been experiencing, how would you go about counseling them? What does the sort of strategy look like day to day? And how do you talk about it without sort of noceboing them, for example?

46:31Austin Baraki:yeah i will be totally up front that this is not an area of a great deal of expertise or experience for me i think that this is a very challenging syndrome number one it is poorly understood it is multifactorial different people experience it in very different ways and they likely have arrived at this kind of like final syndrome probably in different ways as well so that deviates a lot from kind of our more we'll call it more traditional like medical diagnoses if you will, where patients tend to more often present with a kind of more prototypical pattern because so much of diagnosis involves things like pattern recognition, and there might be a relatively common or shared underlying pathophysiology.

47:14Austin Baraki:Here, it might be different pathophysiologies that converge to manifest in a similar way in a diverse set of patients, ultimately not super well understood. Maybe some people have greater or lesser degrees of mitochondrial problems. That's a total hypothesis. And again, I'm not an expert in this area. So as a result, that's why I am both reluctant to sign on to the idea that I'm better than any study here, but also be that, you know, I'm probably not the best person to be giving confident advice on this. I think that a lot of what you proposed is probably reasonable. Although I would also point out that even the best plan that you could propose within those kind of constraints may still fail for a person for reasons that we may understand and may not.

47:55Austin Baraki:And so much more so, I think the idea of individualization, and again, as I alluded to earlier, being on the same team as the person is probably the most useful thing here. So trying to get a sense of like, how do you feel that I can help you best? Are you willing to work together, collaborate on this, iterate on this over time? What are the goals you're trying to achieve? Can we like mutually agree on an acceptable starting point with a plan to modify as we go? because you're right that historically the idea that, oh, these folks, you know, they have this syndrome, but they still are capable of tolerating a stress and adapting to it just like anyone else.

48:28Austin Baraki:It's like might be a little bit of an exception to that rule because when they have been pushed, they tend to do worse. And so there's some other path, some other strategy that's going to need to be worked out. And again, it's going to need to be super individualized to the person and what they're willing to do. I think that both of us would hesitate to sign on to an idea of, well, you're just not going to be able to exert yourself and just like you know bed rest is going to be the move for you that's not something you're likely to ever hear a say for somebody but rather that prospectively without you know meeting with the person working with them got you know collaborating on this over time it's going to be tough to propose something up front that is anything more than like a reasonable guess and that's kind of what you came up with there and with a if then sort of thing so that they have some confidence that hey we got a backup in mind and i like that you included some ideas for backup strategies.

49:18Austin Baraki:But you need to be on the same team. If there's an adversarial sort of relationship, if there is, you know, doubt in the relationship of, oh, well, I don't think that I can tolerate this, but they're making me do it or recommending that I do it. Like you're already kind of on the wrong foot. So you need some rapport, you need some trust, you need some collaboration, you need some iteration, you need a lot of time. If it were me, I would probably be like, hey, can we find somebody with like way more expertise than me in this space who can guide you? Because I've done that for other things that are not necessarily, like I will claim to know a lot about a lot of things, but certainly not everything.

49:50Austin Baraki:And this is one of those areas where unfortunately I do not have a great deal of that expertise. And a lot of that is an artifact or a consequence of my typical practice setting over the years. Working in hospital medicine for a lot of the time and not having like brick and mortar clinic where I'm seeing patients with these sorts of chronic debilitating illnesses limits my degree of experience in working with them. And so then that limits my confidence in giving advice on the internet about it.

50:17Jordan Feigenbaum:Yeah, yeah, well said. And I think if you're a coach working with somebody like this and you've never seen it before, never dealt with it before, I don't wanna scare you off and say, we don't wanna scare you off and say, look, you can't touch this. You know, a little MC Hammer reference, but I would just generally be more conservative and more dynamic with your recommendations, readiness to change, what you're doing. And then further, if you get in a few weeks or a few months and you feel like you really can't get purchased on like, this is where the person should be starting. Generally speaking for the bones of a decent program, you just can't find that entry point.

50:52Jordan Feigenbaum:Then finding somebody with some more specialized expertise would be, would be the move. And I think, you know, we see that all the time in medicine. It's like, look, this looks like something I feel like I can handle. And then, you know, if that doesn't really shake out, okay, cool. We're going to actually call, we're going to get a consultant on board. He's going to help us because they have more expertise. That's a handful of the best questions from this month's direct line. The full episode, every question our members sent in goes out to our Barbell Medicine Plus and premium members every month.

51:18Jordan Feigenbaum:Now, if you want the whole thing each month and you want your own questions to be answered on the show, head over to barbellmedicine.com and jump in. From everyone here at Barbell Medicine, I'm Dr. Jordan Feigenbaum. That's Dr. Austin Baraki. We'll catch you next week and every week right here on the Barbell Medicine Podcast.

51:38you

From the publisher

A popular paper claimed the longevity benefit of lifting disappears once you train more than an hour a week. It's a real paper, but the claim is a misread. This is the free cut of this month's Direct Line, where Drs. Feigenbaum and Baraki also take on whether GLP-1s affect your mood, the "same calories, more weight loss" protein argument, and what you can actually do in the gym when you have chronic fatigue syndrome.

For education and infotainment, not medical advice.

To become a member and have us answer YOUR questions, join today:

https://www.barbellmedicine.com/shop/subscriptions/plus-podcast-subscription/


Timestamps:

0:00 Intro

0:38 The paper: does lifting stop helping after an hour?

3:19 The newer 147,000-person, 30-year study

13:21 GLP-1s, mood, and motivation

14:50 The FDA reverses the suicide warning

19:29 What happened when they gave people a GLP-1 in a bar

24:54 Is a calorie just a calorie?

28:17 The "same calories, more weight loss" protein study

30:48 Does keto break the laws of physics?

34:56 Lifting with chronic fatigue syndrome

36:14 The identical-twin experiment

37:36 Can lifting in bed do anything?

45:33 Get the full Direct Line



Barbell Medicine coaching and templates: https://www.barbellmedicine.com



Barbell Medicine Premium: https://www.barbellmedicine.com/shop/subscriptions/barbell-medicine-premium/


Signal (pre-order)

https://www.barbellmedicine.com/shop/learning/signal/


1. Momma H, Kawakami R, Honda T, Sawada SS. Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies. *Br J Sports Med*. 2022;56(13):755-763. doi:10.1136/bjsports-2021-105061


2. Dankel SJ, Loenneke JP, Loprinzi PD. Dose-dependent association between muscle-strengthening activities and all-cause mortality: prospective cohort study among a national sample of adults in the USA. *Arch Cardiovasc Dis*. 2016;109(11):626-633. doi:10.1016/j.acvd.2016.04.005


3. Zhang Y, Lee DH, Rezende LFM, Ma Y, Giovannucci E. Long-term resistance training with all-cause and cause-specific mortality: assessing dose-response and joint associations with aerobic physical activity. *Br J Sports Med*. Published online June 2, 2026. doi:10.1136/bjsports-2025-110503


4. US Food and Drug Administration. FDA requests removal of suicidal behavior and ideation warning from glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications. Drug Safety Communication. January 13, 2026. Accessed August 12, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requests-removal-suicidal-behavior-and-ideation-warning-glucagon-peptide-1-receptor-agonist-glp


5. Hendershot CS, Bremmer MP, Paladino MB, et al. Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial. *JAMA Psychiatry*. 2025;82(4):395-405. doi:10.1001/jamapsychiatry.2024.4789


6. Klausen MK, Justesen SK, Pedersen JN, et al. Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial. *Lancet*. 2026;407(10540):1687-1698. doi:10.1016/S0140-6736(26)00305-3


7. Haghighat N, Ashtary-Larky D, Bagheri R, et al. The effect of 12 weeks of euenergetic high-protein diet in regulating appetite and body composition of women with normal-weight obesity: a randomised controlled trial. *Br J Nutr*. 2020;124(10):1044-1051. doi:10.1017/S0007114520002019


8. Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Board on the Health of Select Populations, Institute of Medicine. *Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness*. National Academies Press; 2015. Accessed August 12, 2026. https://www.ncbi.nlm.nih.gov/books/NBK274235/


9. Giloteaux L, Hanson MR, Keller BA. A pair of identical twins discordant for myalgic encephalomyelitis/chronic fatigue syndrome differ in physiological parameters and gut microbiome composition. *Am J Case Rep*. 2016;17:720-729. doi:10.12659/AJCR.900314


10. Rangan A, Brealey SD, Keding A, et al. Management of adults with primary frozen shoulder in secondary care (UK FROST): a multicentre, pragmatic, three-arm, superiority randomised clinical trial. *Lancet*. 2020;396(10256):977-989. doi:10.1016/S0140-6736(20)31965-6


11. Millar NL, Meakins A, Struyf F, et al. Frozen shoulder. *Nat Rev Dis Primers*. 2022;8(1):59. doi:10.1038/s41572-022-00386-2


12. US Department of Agriculture, US Department of Health and Human Services. *Dietary Guidelines for Americans, 2025-2030*. January 2026. Accessed August 12, 2026. https://www.dietaryguidelines.gov/



Our Sponsors:
* Check out CovePure and use my code CovePure.com/bbm for a great deal: https://covepure.com
* Check out FIGS: https://wearfigs.com
* Check out Factor and use my code factormeals.com/bbm50off for a great deal: https://www.factor75.com
* Check out Quince and use my code quince.com/BBM for a great deal: https://www.quince.com


Advertising Inquiries: https://redcircle.com/brands

More from Barbell Medicine Podcast

All 79 episodes
Lifting and longevity: is 1 hour a week really the limit? Plus GLP1s and mood, training with ME/CFS, and Protein vs. CaloriesBarbell Medicine Podcast · 46 min
Listen in VO